TSPO and Alzheimer disease: Supporting the notion that microglial activation is primarily beneficial in the context of AD pathology, elevated PET signal for ligands of the “neuroinflammation marker” TSPO have predicted better cognitive measures and slower AD progression in mice with β-amyloid pathology and human patients, respectively (Hamelin et al., 2016; Focke et al., 2019).